Holen Sie sich die Stockscreener-App
13.07
5.83%
0.72
Handel nachbörslich:
14.00
0.93
+7.12%
Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten
Why Zenas BioPharma Inc. stock attracts strong analyst attentionHigh Return Investment Tips - Newser
What makes Zenas BioPharma Inc. stock price move sharplyReturn Optimized Trade Insights - Newser
Zenas BioPharma Insiders Added US$2.11m Of Stock To Their Holdings - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
Citi reiterates Buy rating on Zenas Biopharma stock with $27 price target - Investing.com Canada
ZBIO Crosses Above Key Moving Average Level - Nasdaq
Promising Future for Zenas BioPharma: Buy Rating Backed by Unique Product Advantage and Strong Pipeline Developments - TipRanks
Morgan Stanley assumes coverage on Zenas Biopharma stock with Overweight rating - Investing.com Canada
Innovative Approach and Upcoming Catalysts Drive Buy Rating for Zenas BioPharma - TipRanks
Zenas BioPharma, Inc.(NasdaqGS: ZBIO) dropped from Russell 2000 Growth Index - MarketScreener
Rhumbline Advisers Sells 27,428 Shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO) - Defense World
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesZBIO - Finansavisen
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas - GlobeNewswire
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - Business Wire
Securities Fraud Class Action Filed Against Zenas BioPharma, Inc. (ZBIO)Levi & Korsinsky Reminds Investors of June 16, 2025 - ACCESS Newswire
ZBIO Investors Have Final Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
FINAL ALERT NOTICEZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsZBIO - marketscreener.com
June 16, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ZBIO - Finansavisen
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - The Malaysian Reserve
Join Class Action to Recover Losses from Zenas BioPharma, Inc. (ZBIO)Contact Levi & Korsinsky Before June 16, 2025 - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Zenas BioPharma, Inc. (ZBIO) Class ActionContact Levi & Korsinsky - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
Zenas BioPharma, Inc. Sued for Securities Law Violations – - GlobeNewswire
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm - GuruFocus
Zenas BioPharma, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & ... - Bluefield Daily Telegraph
ZBIO IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW - GlobeNewswire
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
Zenas BioPharma, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationZBIO - PR Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire Inc.
Zenas BioPharma Announces Board Changes at Annual Meeting - TipRanks
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 – ZBIO - TradingView
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
MONDAY INVESTOR DEADLINE: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action LawsuitZBIO - GuruFocus
Investors who lost money on Zenas BioPharma, Inc.(ZBIO) should contact The Gross Law Firm about pending Class ActionZBIO - WV News
Zenas BioPharma, Inc. (ZBIO) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 16, 2025 Deadline - ACCESS Newswire
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire
Faruqi & Faruqi Reminds Zenas BioPharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025ZBIO - StreetInsider
ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, In - GuruFocus
ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsZBIO - Morningstar
Zenas BioPharma, Inc. Investors: Please contact the Portnoy - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - The Malaysian Reserve
Zenas BioPharma, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; June 16, 2025 Deadline to file Lead Plaintiff Motion - TradingView
ZBIO DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, Inc. Investors to ... - Eagle-Tribune
ZBIO DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – ZBIO - TradingView
Zenas BioPharma Class Action Lawsuit Filed by Levi & Korsinsky - Lawyer Monthly
Zenas BioPharma, Inc. Class Action: Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025ZBIO - Kilgore News Herald
Shareholders of Zenas BioPharma, Inc. (ZBIO): Protect Your Rights Before June 16, 2025Contact Levi & Korsinsky - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Investors in Zenas BioPharma, Inc. (ZBIO): Protect Your RightsContact Levi & Korsinsky Before June 16, 2025 - ACCESS Newswire
3.40%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):